Jupiter Neurosciences Inc (JUNS) concluded trading on Wednesday at a closing price of $1.99, with 9.06 million shares of worth about $18.03 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -74.45% during that period and on June 11, 2025 the price saw a gain of about 105.79%. Currently the company’s common shares owned by public are about 33.10M shares, out of which, 14.08M shares are available for trading.
Stock saw a price change of 144.17% in past 5 days and over the past one month there was a price change of 212.89%. Over the period of past 52 weeks, stock dropped to lowest price of $0.51 but also hit the highest price of $19.51 during that period. The average intraday trading volume for Jupiter Neurosciences Inc shares is 252.22K. The stock is currently trading 153.99% above its 20-day simple moving average (SMA20), while that difference is up 190.96% for SMA50 and it goes to -29.18% lower than SMA200.
Jupiter Neurosciences Inc (NASDAQ: JUNS) currently have 33.10M outstanding shares and institutions hold larger chunk of about 1.14% of that.
The stock has a current market capitalization of $65.88M. It has posted earnings per share of -$0.10 in the same period. It has Quick Ratio of 1.91 while making debt-to-equity ratio of 0.07. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for JUNS, volatility over the week remained 34.53% while standing at 17.65% over the month.
Stock’s fiscal year EPS is expected to drop by -212.50% while it is estimated to increase by 144.00% in next year.
